MedTrace Logo

PET/MR for Staging Rectal Cancer Patients With and Without EMVI-MR

NCT02537340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2020-06-22

No results posted yet for this study

Summary

The hypothesis to be proven with this study is that the use of PET/MR on the initial staging of rectal cancers in patients with extramural vascular invasion detected by MR will detect more lesions than conventional work-up and will significantly impact on therapeutic decision, improving disease free and overall survival.

Conditions

  • Rectal Neoplasms

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • Instituto do Cancer do Estado de São Paulo

    lead OTHER

Principal Investigators

  • Carlos Buchpiguel, MD, PhD · University of Sao Paulo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-04-30
Completion
2019-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537340 on ClinicalTrials.gov